Health Trials

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

ConditionsMultiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis RelapseMultiple Sclerosis, Relapsing-Remitting
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorShirley Ryan AbilityLab

About this trial

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Eligibility criteria

Qualifiers

Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS)

Able to ambulate overground

Relapse free for at least 1 month

Age ≥18 and ≤ 75 years

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Camera Based Kinematic Analysis

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

Shirley Ryan AbilityLab

Lead sponsor

Source ClinicalTrials.gov